{"id":"https://openalex.org/W7045843121","doi":null,"title":"Biophysical and structural studies of the ligand-induced interaction of multiple SALL4 zinc finger domains with cereblon","display_name":"Biophysical and structural studies of the ligand-induced interaction of multiple SALL4 zinc finger domains with cereblon","alternate_titles":[],"publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W7045843121"},"language":"en","primary_location":{"id":"pmh:oai:oak.novartis.com:50923","doi":null,"is_oa":false,"landing_page_url":"https://oak.novartis.com/50923/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400709","display_name":"The Novartis Repository (Novartis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1283582996","host_organization_name":"Novartis (Switzerland)","host_organization_lineage":["https://openalex.org/I1283582996"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},"parent_works":[],"lineage":["https://openalex.org/W7045843121"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078481930","display_name":"Charles A. Wartchow","orcid":"https://orcid.org/0000-0002-0123-1455","observed_orcids":["https://orcid.org/0000-0002-0123-1455"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wartchow, Charles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5078481930"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1315","display_name":"Structural Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sall4","display_name":"SALL4","score":0.9549999833106995},{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.9900000095367432},{"id":"https://openalex.org/keywords/zinc-finger","display_name":"zinc finger","score":0.722000002861023},{"id":"https://openalex.org/keywords/molecular-glue-degraders","display_name":"molecular glues","score":0.8930000066757202},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.824999988079071},{"id":"https://openalex.org/keywords/pomalidomide","display_name":"pomalidomide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ddb1","display_name":"DDB1","score":0.8690000176429749},{"id":"https://openalex.org/keywords/protein-protein-interaction","display_name":"protein-protein interaction","score":0.6179999709129333},{"id":"https://openalex.org/keywords/selective-protein-degradation","display_name":"selective protein degradation","score":0.6140000224113464},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.6790000200271606},{"id":"https://openalex.org/keywords/binding-selectivity","display_name":"binding selectivity","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2778540781","wikidata":"https://www.wikidata.org/wiki/Q21112029","display_name":"Cereblon","level":5,"score":0.6409000158309937},{"id":"https://openalex.org/C24284526","wikidata":"https://www.wikidata.org/wiki/Q204785","display_name":"Zinc finger","level":4,"score":0.48170000314712524},{"id":"https://openalex.org/C2778283623","wikidata":"https://www.wikidata.org/wiki/Q18032200","display_name":"TSG101","level":5,"score":0.35569998621940613},{"id":"https://openalex.org/C36503486","wikidata":"https://www.wikidata.org/wiki/Q11235244","display_name":"Domain (mathematical analysis)","level":2,"score":0.2651999890804291},{"id":"https://openalex.org/C2777751087","wikidata":"https://www.wikidata.org/wiki/Q5636047","display_name":"HT1080","level":3,"score":0.2615000009536743},{"id":"https://openalex.org/C35802184","wikidata":"https://www.wikidata.org/wiki/Q204773","display_name":"Zinc finger nuclease","level":5,"score":0.26019999384880066},{"id":"https://openalex.org/C2780976139","wikidata":"https://www.wikidata.org/wiki/Q14906081","display_name":"Amphiphysin","level":5,"score":0.25859999656677246},{"id":"https://openalex.org/C2908868211","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin-Protein Ligases","level":5,"score":0.21539999544620514},{"id":"https://openalex.org/C5432534","wikidata":"https://www.wikidata.org/wiki/Q24722007","display_name":"LIM domain","level":5,"score":0.2134000062942505},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.20819999277591705}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:oak.novartis.com:50923","doi":null,"is_oa":false,"landing_page_url":"https://oak.novartis.com/50923/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400709","display_name":"The Novartis Repository (Novartis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1283582996","host_organization_name":"Novartis (Switzerland)","host_organization_lineage":["https://openalex.org/I1283582996"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389607241","https://openalex.org/W3015039243","https://openalex.org/W2478033379","https://openalex.org/W3085433450","https://openalex.org/W4308439092","https://openalex.org/W2891071960","https://openalex.org/W4414518010","https://openalex.org/W2589657844","https://openalex.org/W4411257636"],"abstract_inverted_index":{"Although":[0],"several":[1],"proteins":[2,240],"are":[3,164],"known":[4,129],"to":[5,130,141,173,180,187,196],"interact":[6,131],"with":[7,84,132,166,183,241,254],"cereblon":[8,63,117,146,163,215,242],"in":[9,64,78,147,176,214,223],"the":[10,16,57,65,79,111,123,142,148,155,189,197,203,224,233,249],"presence":[11,66,80],"of":[12,19,25,56,67,73,76,81,116,145,154,162,191,232,237,252,259],"molecular":[13,17,234],"glues":[14],"(MGs),":[15],"basis":[18],"selectivity":[20],"is":[21,28,44,128,200],"emerging.":[22],"An":[23],"understanding":[24,55,231],"these":[26,82,167],"interactions":[27,108,236],"important":[29],"when":[30],"designing":[31],"drugs":[32],"that":[33,127,219],"selectively":[34],"degrade":[35],"a":[36,74,90,99,102],"given":[37],"target":[38],"while":[39],"sparing":[40],"others.":[41],"SALL4":[42,85,119,138,217],"degradation":[43,258],"undesirable":[45],"and":[46,49,70,101,118,157,207,216,243,257],"X-ray":[47],"crystallography":[48],"biophysical":[50],"binding":[51,59,92,152,190,256],"studies":[52,209,228],"expand":[53],"our":[54,230],"minimal":[58],"domain":[60,113,115,144],"recognized":[61],"by":[62],"IMiDs":[68,83],"pomalidomide":[69,205],"CC-220.":[71],"Structures":[72],"complex":[75,199],"DDB1:CRBN":[77],"zinc":[86,97,104,159,238],"finger":[87,160],"domains":[88,161,195],"reveal":[89],"novel":[91],"mode":[93],"involving":[94],"two":[95],"adjacent":[96,137],"fingers-":[98],"primary":[100,107],"secondary":[103],"finger.":[105],"The":[106,151],"occur":[109,222],"between":[110],"C-terminal":[112,171],"IMiD-binding":[114],"ZF2,":[120],"which":[121],"contains":[122],"canonical":[124],"CXXCG":[125],"motif":[126],"cereblon:pomalidomide":[133],"complexes.":[134],"In":[135],"addition,":[136],"ZF1":[139,218],"binds":[140],"N-terminal":[143],"\u201cclosed\u201d":[149],"form.":[150],"affinities":[153],"single":[156],"double":[158],"consistent":[165],"structural":[168,208,212,246],"elements.":[169],"Adding":[170],"residues":[172],"ZF2":[174,192],"results":[175],"increased":[177],"potency":[178],"due":[179],"additional":[181],"contacts":[182],"cereblon.":[184],"With":[185],"respect":[186],"selectivity,":[188],"or":[193],"ZF1-2":[194],"CRBN:CC-220":[198],"weaker":[201],"than":[202],"corresponding":[204,225],"complexes":[206],"suggest":[210],"subtle":[211],"changes":[213],"do":[220],"not":[221],"pomalidomide.":[226],"These":[227],"further":[229],"glue-mediated":[235],"finger-based":[239],"may":[244],"provide":[245],"tools":[247],"for":[248],"prospective":[250],"design":[251],"compounds":[253],"reduced":[255],"SALL4.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7045843121","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-10T00:00:00"}
